Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review
Open accessThe DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Abstract
Cartilage degeneration is a key feature of aging and osteoarthritis, characterized by the progressive deterioration of joint function, pain, and limited mobility. Current treatments focus on symptom relief, not cartilage regeneration. Mesenchymal stromal cells (MSCs) offer a promising therapeutic option due to their capability to differentiate into chondrocytes, modulate inflammation, and promote tissue regeneration. This review explores the potential of MSCs for cartilage regeneration, examining their biological properties, action mechanisms, and applications in preclinical and clinical settings. MSCs derived from bone marrow, adipose tissue, and other sources can self-renew and differentiate into multiple cell types. In aging cartilage, they aid in tissue regeneration by secreting growth factors and cytokines that enhance repair and modulate immune responses. Recent preclinical studies show that MSCs can restore cartilage integrity, reduce inflammation, and improve joint function, although clinical translation remains challenging due to limitations such as cell viability, scalability, and regulatory concerns. Advancements in MSC delivery, including scaffold-based approaches and engineered exosomes, may improve therapeutic effectiveness. Potential risks, such as tumorigenicity and immune rejection, are also discussed, emphasizing the need for optimized treatment protocols and large-scale clinical trials to develop effective, minimally invasive therapies for cartilage regeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MSC-based therapies demonstrate superior potential in cartilage repair and osteoarthritis, yet high costs and regulatory barriers hinder clinical adoption [125,126].”
From Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications (2025) · cites this paper as [125]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“PRP provides short-term symptomatic relief, particularly in tendon and ligament injuries, but variability in preparation limits its long-term efficacy [124,125].”
From Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications (2025) · cites this paper as [125]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cross, M., Smith, E., Hoy, D., Nolte, S., Ackerman, I., Fransen, M., Bridgett, L., Williams, S., Guillemin, F., Hill, C. L., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204763 · Cited by 3,496 · cited 1×
“Hip and knee OA are particularly significant, ranking as the 11th highest contributor to global disability in 2010 [4].”
Safiri, S., Kolahi, A.-A., Smith, E., Hill, C., Bettampadi, D., Mansournia, M. A., Hoy, D., Ashrafi-Asgarabad, A., Sepidarkish, M., Almasi-Hashiani, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216515 · Cited by 1,651 · cited 2×
“From 1990 to 2017, the global age-standardized prevalence of OA increased by 9.3% to 3754.2 per 100,000 [2].”
InfluentialChallenges and directions in studying cell–cell communication by extracellular vesicles
van Niel, G., Carter, D. R. F., Clayton, A., Lambert, D. W., Raposo, G., & Vader, P. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00460-3 · Cited by 1,229 · cited 2×
“They show promise as biomarkers, therapeutic agents, and drug delivery vehicles [131].”
Osteoarthritis: pathogenic signaling pathways and therapeutic targets
Yao, Q., Wu, X., Tao, C., Gong, W., Chen, M., Qu, M., Zhong, Y., He, T., Chen, S., & Xiao, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01330-w · Cited by 1,194 · cited 1×
“Currently, OA management primarily focuses on symptom relief, joint function improvement, and quality of life enhancement, as no treatments are available to reverse cartilage degeneration [10].”
Stem cell therapy in a caprine model of osteoarthritis
Murphy, J. M., Fink, D. J., Hunziker, E. B., & Barry, F. P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11365 · Cited by 1,102 · cited 1×
“In sheep and goat models, some studies reported improvements, while others found no significant differences be-tween MSC-treated and control groups [89,90].”
Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential
Song, N., Scholtemeijer, M., & Shah, K. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.06.009 · Cited by 948 · cited 2×
“MSCs inhibit the activation and proliferation of immune cells, such as T cells and natural killer cells, reducing inflammation and preventing excessive tissue damage [40,41].”
Jo, C. H., Lee, Y. G., Shin, W. H., Kim, H., Chai, J. W., Jeong, E. C., Kim, J. E., Shim, H., Shin, J. S., Shin, I. S., et al. (2014) · STEM CELLS · doi:10.1002/stem.1634 · Cited by 911 · cited 3×
“Magnetic resonance imaging revealed decreased cartilage defects and increased cartilage volume in treated knees [168,169].”
InfluentialDing, D.-C., Shyu, W.-C., & Lin, S.-Z. (2011) · Cell Transplantation · doi:10.3727/096368910x · Cited by 894 · cited 3×
“Other potential sources include dental pulp, synovial membrane, and placental tissue, all of which contribute to the expanding range of options for MSC-based therapies [16].”
InfluentialSelf-citationRisk factors in the development of stem cell therapy
Herberts, C. A., Kwa, M. S., & Hermsen, H. P. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-29 · Cited by 753 · cited 3×
“Although most small-scale clinical trials using MSCs have not reported major health concerns, some serious adverse events have occurred, emphasizing the need for continued research on their long-Int term safety [214].”
Han, Y., Yang, J., Fang, J., Zhou, Y., Candi, E., Wang, J., Hua, D., Shao, C., & Shi, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00932-0 · Cited by 720 · cited 3×
“These cells modulate immune responses through secretion of various bioactive factors, including cytokines, growth factors, and extracellular vesicles (EVs), which help create a favorable microenvironment for tissue repair [38,39].”
Cited by
Mesenchymal stem cell-derived exosomes: A paradigm shift in clinical therapeutics
Chattopadhyay, S., Rajendran, R. L., Chatterjee, G., Reyaz, D., Prakash, K., Hong, C. M., Ahn, B., ArulJothi, K. N., & Gangadaran, P. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114616 · Cited by 31
Goulian, A. J., Goldstein, B., & Saad, M. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14062061 · Cited by 25
“PRP provides short-term symptomatic relief, particularly in tendon and ligament injuries, but variability in preparation limits its long-term efficacy [124,125].”
Nonaka, T., Murata, D., Yoshizato, H., Kashimoto, S., Nakamura, A., Morimoto, T., & Nakayama, K. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-05604-7 · Cited by 16
“Therefore, cartilage constructs with an appropriate thickness are difficult to fabricate [24].”
The role of synovial mesenchymal stem cell-derived exosomes in cartilage repair: a systematic review
Su, J., Qi, Y., Niu, L., Wang, Y., Wei, B., Ma, B., Kong, K., Zhai, Z., & Xu, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1617874 · Cited by 13
“Irreversible changes in knee joint structure: exosomes are unable to directly repair osteophytes or reconstruct severely worn cartilage layers, but may reduce pain and in fl ammation by regulating the remaining subchondral bone to talk to the synovium (Wu et al., 2024).”
Coleman, L. J., Byrne, J. L., Edwards, S., & O’Hara, R. (2025) · Biologics · doi:10.3390/biologics5030027 · Cited by 15
“More recent advances include hydrogels, gene therapy, and stem cell-based approaches show promise, particularly mesenchymal stromal cells for their regenerative and anti-inflammatory properties, though delivery, safety, and scalability challenges persist [54,55].”
Metadata
- Authors
- Wu, K.-C., Chang, Y.-H., Ding, D.-C., & Lin, S.-Z.
- Affiliations
- Tzu Chi University (TW)
- Corresponding author
- Ding, Dah-Ching
- Lin, Shinn-Zong
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2024-11-30
- Volume
- 25
- Issue
- 23
- Pages
- 12911
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC11641625
- OpenAlex
- W4404903366
- Cited by
- 33
- References
- 228
- Citations by year
- 2026: 22 · 2025: 11
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- NSTC (113-2314-B-303-024)
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Keywords
- mesenchymal stem cells, cartilage regeneration, osteoarthritis, cartilage degeneration, chondrogenic differentiation, growth factor secretion, inflammation modulation, bone marrow-derived MSCs, adipose-derived MSCs, exosomes, tumorigenicity, immune rejection, clinical translation
- MeSH terms
- Aging, Animals, Cartilage, Cartilage, Articular, Cell Differentiation, Humans, Osteoarthritis, Regeneration, Chondrocytes, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review. https://app.cochat.ai/papers/10.3390/ijms252312911
- The paper
- Wu, K.-C., Chang, Y.-H., Ding, D.-C., & Lin, S.-Z. (2024). Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312911
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.